Implementation of a Population-Based Cirrhosis Identification and Management System
Cirrhosis-related morbidity and mortality is potentially preventable. Antiviral treatment in patients with cirrhosis-related to hepatitis C virus (HCV) or hepatitis B virus can prevent complications.1 –3 Beta-blockers and endoscopic treatments of esophageal varices are effective in primary prophylaxis of variceal hemorrhage.4 Surveillance for hepatocellular cancer is associated with increased detection of early stage cancer and improved survival.5 However, many patients with cirrhosis are eithe r not diagnosed in a primary care setting, or even when diagnosed, not seen or referred to specialty clinics to receive disease-specific care,6 and thus remain at high risk for complications.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Fasiha Kanwal, Srikar Mapaskhi, Donna Smith, Tamar Taddei, Khozema Hussain, Stella Madu, Ngoc Duong, Donna White, Yumei Cao, Rajni Mehta, Hashem El-Serag, Steven Asch, Amanda Midboe Tags: Practice management: The road ahead Source Type: research
More News: Beta-Blockers | Cancer | Cancer & Oncology | Cirrhosis | Esophagus Cancer | Gastroenterology | Hepatitis | Hepatitis B | Hepatitis C | Practice Management | Practice Management Systems | Primary Care